A class action lawsuit has been filed against Dexcom (Nasdaq:DXCM) in the U.S. District Court for the Central District of ...
Investors have filed a lawsuit claiming Baxter (NYSE:BAX) violated federal securities laws as a result of issues with certain ...
Civica announced today that it plans to launch an affordable long-acting insulin in pre-filled pens starting in January 2026.
Abbott continues to get a boost in its Medical Devices business from its Diabetes unit's portfolio of continuous glucose ...
The t:slim X2 system (left) and FreeStyle Libre 3 (right). [Images courtesy of Tandem Diabetes Care and Abbott] On social media, Tandem Diabetes Care (Nasdaq:TNDM) said the launch of a new integration ...
MannKind (Nasdaq:MNKD) announced today that the FDA accepted a supplemental biologics license for its Afrezza inhaled insulin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback